Leonhard S, Papri N, Querol L, Rinaldi S, Shahrizaila N, Jacobs B
Nat Rev Dis Primers. 2024; 10(1):97.
PMID: 39702645
DOI: 10.1038/s41572-024-00580-4.
Rustagi V, Gupta S, Talwar C, Singh A, Xiao Z, Jamwal R
Immunol Res. 2024; 73(1):17.
PMID: 39692912
DOI: 10.1007/s12026-024-09553-x.
Yazdani A, Mirmosayyeb O, Sadeghi M, Ghoshouni H, Tavakol G, Ghajarzadeh M
Maedica (Bucur). 2024; 19(2):410-416.
PMID: 39188850
PMC: 11345054.
DOI: 10.26574/maedica.2024.19.2.410.
Oliveira A, Varela Ramos P, Durao-Carvalho G, Almeida V, Goncalves Pereira J
Cureus. 2024; 16(4):e57705.
PMID: 38711707
PMC: 11071625.
DOI: 10.7759/cureus.57705.
Hayashi R, Yamaguchi S
Intern Med. 2023; 62(20):3053-3056.
PMID: 37532545
PMC: 10641199.
DOI: 10.2169/internalmedicine.2339-23.
Uptake of severe acute respiratory syndrome coronavirus 2 spike protein mediated by angiotensin converting enzyme 2 and ganglioside in human cerebrovascular cells.
McQuaid C, Solorzano A, Dickerson I, Deane R
Front Neurosci. 2023; 17:1117845.
PMID: 36875642
PMC: 9980911.
DOI: 10.3389/fnins.2023.1117845.
Guillain-Barré syndrome associated with COVID-19: A systematic review.
Pimentel V, Luchsinger V, Carvalho G, Alcara A, Esper N, Marinowic D
Brain Behav Immun Health. 2023; 28:100578.
PMID: 36686624
PMC: 9842533.
DOI: 10.1016/j.bbih.2022.100578.
Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Case Report.
Gunawan P, Tiffani P, Lalisang L
Clin Psychopharmacol Neurosci. 2022; 20(4):777-780.
PMID: 36263653
PMC: 9606431.
DOI: 10.9758/cpn.2022.20.4.777.
Guillain-Barré syndrome following SARS-CoV-2 vaccination in the UK: a prospective surveillance study.
Tamborska A, Singh B, Leonhard S, Hodel E, Stowe J, Watson-Fargie T
BMJ Neurol Open. 2022; 4(2):e000309.
PMID: 35856053
PMC: 9277028.
DOI: 10.1136/bmjno-2022-000309.
Case Series of Guillain-Barré Syndrome After the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) Vaccine.
Wan M, Lee A, Kapadia R, Hahn C
Neurol Clin Pract. 2022; 12(2):149-153.
PMID: 35747886
PMC: 9208400.
DOI: 10.1212/CPJ.0000000000001148.
Prognosis of Guillain-Barré Syndrome Linked to COVID-19 Vaccination.
Chua S, Soh Q, Saffari S, Tan E
Brain Sci. 2022; 12(6).
PMID: 35741597
PMC: 9220921.
DOI: 10.3390/brainsci12060711.
LGI-1 encephalopathy following ChAdOx1 nCov-19 vaccination.
Garibashvili T, Heckmann J
Neurol Res Pract. 2022; 4(1):24.
PMID: 35718786
PMC: 9206881.
DOI: 10.1186/s42466-022-00187-8.
Guillain-Barré syndrome following coronavirus disease vaccine: First report from Nepal.
Luitel P, Poudel B, Upadhyay D, Paudel S, Tiwari N, Gajurel B
SAGE Open Med Case Rep. 2022; 10:2050313X221100876.
PMID: 35646371
PMC: 9130842.
DOI: 10.1177/2050313X221100876.
Bilateral facial palsy with paresthesias, variant of Guillain-Barré syndrome following COVID-19 vaccine: A case series of 9 patients.
Castiglione J, Crespo J, Lecchini L, Silveira F, Luis M, Cotti N
Neuromuscul Disord. 2022; 32(7):572-574.
PMID: 35644722
PMC: 9090822.
DOI: 10.1016/j.nmd.2022.05.003.
Neuromuscular complications after COVID-19 vaccination: a series of eight patients.
Leemans W, Antonis S, De Vooght W, Lemmens R, Van Damme P
Acta Neurol Belg. 2022; 122(3):753-761.
PMID: 35499704
PMC: 9059449.
DOI: 10.1007/s13760-022-01941-0.
A review of adverse effects of COVID-19 vaccines.
Mushtaq H, Khedr A, Koritala T, Bartlett B, Jain N, Khan S
Infez Med. 2022; 30(1):1-10.
PMID: 35350266
PMC: 8929726.
DOI: 10.53854/liim-3001-1.
A call for vigilance: thrombotic thrombocytopenic syndrome caused by mRNA COVID-19 vaccine associated with muscle weakness.
Kim C, Kwak J, Jang S, Bang S
Blood Res. 2022; 57(1):1-3.
PMID: 35342039
PMC: 8958373.
DOI: 10.5045/br.2022.2021134.
COVID-19 Vaccination and Neurological Manifestations: A Review of Case Reports and Case Series.
Sriwastava S, Sharma K, Khalid S, Bhansali S, Shrestha A, Elkhooly M
Brain Sci. 2022; 12(3).
PMID: 35326363
PMC: 8946610.
DOI: 10.3390/brainsci12030407.
[Clinical cases of Guillain-Barré and Miller-Fisher syndromes linked to COVID-19].
Jasso-Rangel M, Vargas-Martinez K, Camacho-Frausto L, Galindo-Felix A, Roman-Esquivel J, Lara-Ramirez E
Rev Med Inst Mex Seguro Soc. 2022; 60(1):91-95.
PMID: 35274917
PMC: 10395868.
Post COVID-19 Vaccination-Associated Neurological Complications.
Assiri S, Althaqafi R, Alswat K, Alghamdi A, Alomairi N, Nemenqani D
Neuropsychiatr Dis Treat. 2022; 18:137-154.
PMID: 35140464
PMC: 8818972.
DOI: 10.2147/NDT.S343438.
